Alcon (ALC) Cash from Operations Growth (1y) (2010 - 2026)
Powered by 
Analysis
Alcon (ALC) Cash from Operations Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.01 Bn | 172.41 Bn | 7.27 Bn | 21.54% |
| 2 | Intuitive Surgical | 131.29 Bn | 126.08 Bn | 1.96 Bn | 48.31% |
| 3 | Medtronic | 116.38 Bn | 107.56 Bn | 6.34 Bn | 64.80% |
| 4 | Stryker | 106.01 Bn | 102.53 Bn | 4.50 Bn | 13.50% |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | 14.62% |
| 6 | Edwards Lifesciences | 48.89 Bn | 44.64 Bn | 1.35 Bn | 124.64% |
| 7 | Alcon | 32.59 Bn | 31.13 Bn | 1.68 Bn | 0.99% |
| 8 | Dexcom | 31.84 Bn | 29.89 Bn | 830.00 Mn | -11.16% |
| 9 | Steris | 20.61 Bn | 20.13 Bn | 684.20 Mn | -12.60% |
| 10 | Zimmer Biomet Holdings | 18.00 Bn | 17.59 Bn | 1.54 Bn | 18.40% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.99% |
| Dec 31, 2025 | 43.36% |
| Sep 30, 2025 | -3.08% |
| Jun 30, 2025 | -4.72% |
| Dec 31, 2024 | 1.77% |
| Sep 30, 2024 | 41.75% |
| Jun 30, 2024 | 63.08% |
| Mar 31, 2024 | 301.18% |
| Dec 31, 2023 | 30.72% |
| Sep 30, 2023 | 31.09% |
| Jun 30, 2023 | -19.55% |
| Mar 31, 2023 | 28.79% |
| Dec 31, 2022 | -10.85% |
| Sep 30, 2022 | -3.37% |
| Jun 30, 2022 | 4.66% |
| Mar 31, 2022 | -57.69% |
| Dec 31, 2021 | -11.85% |
| Sep 30, 2021 | 27.61% |
| Jun 30, 2021 | 1,278.57% |
| Mar 31, 2021 | 420.00% |